RARPKB

Groups information

Group name

Whole-gland treatment (Total)

BCR

BCR

11 (24)

p-value

0.51

remark

Recurrence, n (%)

Continence

Continence

44 (98)

p-value

0.303

remark

Erectile dysfunction, n (%)

Sexual Function

PSA

Complications or other prognosis

Complications or other prognosis

14 (31)

p-value

0.269

remark

Need for further ADT, n (%)

Positive surgical margin (PSM)

Other quality of life

Surgical related outcomes

Survival Outcome

Survival Outcome

Other outcomes

Follow Up Time

Follow Up Time

/